In one paragraphArticle in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Aykut DemirkolJonas Children's Vision Care and Bernard & Shirlee Brown Glaucoma Laboratory, Institute of Human Nutrition, Columbia Stem Cell Initiative, New York, NY 10032, USA.ORCID 0000-0001-6738-1643 Esra SahliJonas Children's Vision Care and Bernard & Shirlee Brown Glaucoma Laboratory, Institute of Human Nutrition, Columbia Stem Cell Initiative, New York, NY 10032, USA.ORCID 0000-0002-1355-7284 Baichun HouJonas Children's Vision Care and Bernard & Shirlee Brown Glaucoma Laboratory, Institute of Human Nutrition, Columbia Stem Cell Initiative, New York, NY 10032, USA.ORCID 0009-0003-3045-8813 Promie R FaruqueJonas Children's Vision Care and Bernard & Shirlee Brown Glaucoma Laboratory, Institute of Human Nutrition, Columbia Stem Cell Initiative, New York, NY 10032, USA.
Ilay DemirkolJonas Children's Vision Care and Bernard & Shirlee Brown Glaucoma Laboratory, Institute of Human Nutrition, Columbia Stem Cell Initiative, New York, NY 10032, USA.
Kuzey SoydasJonas Children's Vision Care and Bernard & Shirlee Brown Glaucoma Laboratory, Institute of Human Nutrition, Columbia Stem Cell Initiative, New York, NY 10032, USA.
Stephen H TsangJonas Children's Vision Care and Bernard & Shirlee Brown Glaucoma Laboratory, Institute of Human Nutrition, Columbia Stem Cell Initiative, New York, NY 10032, USA.ORCID 0000-0001-9082-2427 Funding
Jonas Children's Vision Care is supported by the National Institute of Health, U01EY030580, U01EY034590 R24EY028758, R24EY027285, R01EY033770, R01EY018213, and R01EY024698; the Foundation Fighting Blindness TA-GT-0321-0802-COLU-TRAP; the Lynette and Richard Jaffe Foundation; the NYEE Foundation; the Rosenbaum Family Foundation; the Gebroe Family Foun-dation; the Phanaphat Family Foundation; the Research to Prevent Blindness
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
chromatic testingclinical endpointcone dysfunctionfull-field stimulus thresholdinherited retinal dystrophyrod–cone dysfunction
Identifiers
PMID41751276
PMCPMC12937628
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390